WANDA BEARING
920002
HENDERA
831152
LINGOOD
833284
WUHAN LAND
830779
TECHVISION
832876
CN Stock MarketDetailed Quotes
301207 Hualan Biological Vaccine Inc.
- 18.05
- -0.08-0.44%
Market Closed Feb 27 15:00 CST
10.85BMarket Cap21.80P/E (TTM)
18.17High17.77Low24.12KlotVolume18.09Open18.13Pre Close43.35MTurnover1.70%Turnover Ratio12.61P/E (Static)601.03MShares24.8652wk High1.78P/B2.56BFloat Cap15.4252wk Low21.76Limit Up141.65MShs Float52.25Historical High14.50Limit Down2.21%Amplitude15.42Historical Low0.60Dividend TTM17.98Avg Price13.37KlotAsk3.32%Div YieldTTM100Lot Size10.33KlotBid
Hualan Biological Vaccine Inc. News
Hualan Vaccine: Announcement on the resignation of the company\'s board secretary and financial director and the appointment of the director and general manager to act as board secretary and financial director
Hualan Vaccine: Summary table on the use of non-operating funds and other related financial transactions
Hualan Biological Vaccine Inc.: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Hualan Biological Vaccine Inc.: Legal Opinion of Anhui Chengyi Law Firm on Holding the First Extraordinary Shareholders' Meeting of Hualan Vaccine in 2024
Hualan Biological Vaccine Inc.: Announcement on Supplementary Election of Independent Directors and Adjustment of Special Committees of the Second Board of Directors.
Hualan Biological Vaccine Inc.: Announcement on increasing registered capital and revising the company's articles of association.
Hualan Biological Vaccine Inc.: Notice of the First Extraordinary Shareholders' Meeting in 2024
Hualan Biological Vaccine Inc.: Announcement Regarding Resignation of Independent Director.
Hualan Biological Vaccine Inc.: Announcement on the Adjustment of Prices for the Company's Main Products
Hualan Vaccine: Legal Opinion of Anhui Chengyi Law Firm on Hualan Biovaccine Co., Ltd. holding the 2023 Annual General Meeting of Shareholders
Hualan Vaccine: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hualan Vaccine: Announcement on the Use of Own Funds for Outsourced Financial Management
Hualan Vaccine: Internal Control Self-Assessment Report
Hualan Vaccine: Announcement on amending the company's articles of association and its annexes
Hualan Vaccine: Announcement on preparations for asset impairment in 2023
Hualan Vaccine: Board of Directors Rules of Procedure (March 2024)
Hualan Vaccine: Notice on holding the 2023 Annual General Meeting of Shareholders
Hualan Vaccine: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Hualan Vaccine: Announcement on receiving a warning letter from the Henan Securities Regulatory Bureau
Hualan Vaccine: Notice on changing the company\'s English name and English abbreviation and amending the “Articles of Association” to complete industrial and commercial registration
